293 related articles for article (PubMed ID: 9766497)
1. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
Benderra Z; Morjani H; Trussardi A; Manfait M
Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
[TBL] [Abstract][Full Text] [Related]
2. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
[TBL] [Abstract][Full Text] [Related]
3. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Int J Oncol; 1998 Mar; 12(3):711-5. PubMed ID: 9472114
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
[TBL] [Abstract][Full Text] [Related]
6. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Pgp- and MRP-mediated multidrug resistance in leukemia cell lines.
Gong YP; Liu T; Jia YQ; Qin L; Deng CQ; Yang RY
Int J Hematol; 2002 Feb; 75(2):154-60. PubMed ID: 11939261
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
9. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
Nielsen D; Maare C; Eriksen J; Litman T; Skovsgaard T
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1050-7. PubMed ID: 11704330
[TBL] [Abstract][Full Text] [Related]
10. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
Kim WJ; Kakehi Y; Yoshida O
Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
[TBL] [Abstract][Full Text] [Related]
11. VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
Minderman H; O'Loughlin KL; Pendyala L; Baer MR
Clin Cancer Res; 2004 Mar; 10(5):1826-34. PubMed ID: 15014037
[TBL] [Abstract][Full Text] [Related]
12. Sequential emergence of MRP- and MDR1-gene over-expression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines.
Zhou DC; Ramond S; Viguie F; Faussat AM; Zittoun R; Marie JP
Int J Cancer; 1996 Jan; 65(3):365-71. PubMed ID: 8575859
[TBL] [Abstract][Full Text] [Related]
13. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
[TBL] [Abstract][Full Text] [Related]
14. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells.
Grech KV; Davey RA; Davey MW
Biochem Pharmacol; 1998 Apr; 55(8):1283-9. PubMed ID: 9719484
[TBL] [Abstract][Full Text] [Related]
15. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.
Zaman GJ; Lankelma J; van Tellingen O; Beijnen J; Dekker H; Paulusma C; Oude Elferink RP; Baas F; Borst P
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7690-4. PubMed ID: 7644478
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
[TBL] [Abstract][Full Text] [Related]
19. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.
Chuman Y; Chen ZS; Seto K; Sumizawa T; Furukawa T; Tani A; Haraguchi M; Niwa K; Yamada K; Aikou T; Akiyama S
Cancer Lett; 1998 Jul; 129(1):69-76. PubMed ID: 9714337
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
